TrialThe Lancet. Respiratory medicine2021

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

Jozefien Declercq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.